Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pHLuc, a Ratiometric Luminescent Reporter for in vivo Monitoring of Tumor Acidosis.
Ong TT, Ang Z, Verma R, Koean R, Tam JKC, Ding JL
Front Bioeng Biotechnol. 2020 May 8;8:412. doi: 10.3389/fbioe.2020.00412. eCollection 2020.
PubMed Article

Plasmids from Article

ID Plasmid Purpose  
141082SEP-Nanoluc-cyOFP1prototype of the bioluminescent reporter pHLuc, for detecting extracellular pH changes in tumor acidosis
Loading...
141084SEPLuc-E2A-cyOFP1precursor of the bioluminescent reporter pHLuc, for detecting extracellular pH changes in tumor acidosis
Loading...
141085SEPLuc-IRES-Antaresprecursor of the bioluminescent reporter pHluc, for detecting extracellular pH changes in tumor acidosis
Loading...
141086Antares-SEPLucprecursor of the bioluminescent reporter pHluc, for detecting extracellular pH changes in tumor acidosis
Loading...
141087Antares-SEPLuc IRESv24precursor of the bioluminescent reporter pHluc, for detecting extracellular pH changes in tumor acidosis; utilizes weaker mutant of IRES
Loading...
141088Antares-SEPLuc C1A4Eprecursor of the bioluminescent reporter pHluc, for detecting extracellular pH changes in tumor acidosis; utilizes weaker mutant of IRES and weaker precursor of Nanoluc
Loading...
141089pHLuc (Antares-SEPLuc C1A4E+6)final optimized bioluminescent reporter for detecting extracellular pH changes in tumor acidosis
Loading...
141091pHLuc ControlpH-stable bioluminescent reporter that serves as the control counterpart of pHLuc; utilizes eGFP instead of SEP
Loading...

Antibodies from Article